Danielle Armas
Celerion (United States)(US)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Pharmacological Effects and Toxicity Studies, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment
Most-Cited Works
- → Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects(2015)74 cited
- → A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants(2022)59 cited
- → Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer(2020)51 cited
- → Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD‐6972 in healthy subjects and subjects with type 2 diabetes mellitus(2016)49 cited
- → Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants(2020)42 cited
- → Identifying Patients at Risk for Obstructive Sleep Apnea in a Primary Care Practice(2011)40 cited
- → Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19(2022)32 cited
- → A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation(2015)27 cited
- → First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults(2019)21 cited
- → Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants(2024)11 cited